Sevikar 40 mg / 5 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

sevikar 40 mg / 5 mg

daiichi sankyo europe gmbh - olmesartanmedoksomil / amlodipinbesilat - tablett, filmdrasjert - 40 mg / 5 mg

Sevikar 20 mg / 5 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

sevikar 20 mg / 5 mg

daiichi sankyo europe gmbh - olmesartanmedoksomil / amlodipinbesilat - tablett, filmdrasjert - 20 mg / 5 mg

Sevikar 40 mg / 10 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

sevikar 40 mg / 10 mg

daiichi sankyo europe gmbh - olmesartanmedoksomil / amlodipinbesilat - tablett, filmdrasjert - 40 mg / 10 mg

Tukysa Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.